BIO-RAD LABORATORIES, INC. — Director's Dealing 2018

Sep 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-04

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-04	Restricted Stock Units	$0	A	13000	Acquired		Bio-Rad A Common Stock (13000)	Direct
2018-09-04	Non-Qualified Stock Option (right to buy)	$326.15	A	13000	Acquired	2028-09-04	Bio-Rad A Common Stock (13000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	411252	Direct
Bio-Rad B Common Stock	12717	Indirect
Bio-Rad B Common Stock	4060054	Indirect
Bio-Rad B Common Stock	256145	Direct

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F5: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.